A plasmonic chip for biomarker discovery and diagnosis of type 1 diabetes.
about
Single nanoparticle plasmonic sensorsLaboratory Diagnosis of Congenital ToxoplasmosisThree dimensions of the amyloid hypothesis: time, space and 'wingmen'Ultrasensitive Antibody Detection by Agglutination-PCR (ADAP)Multitarget, quantitative nanoplasmonic electrical field-enhanced resonating device (NE2RD) for diagnostics.A prospective randomized trial examining health care utilization in individuals using multiple smartphone-enabled biosensorsLive imaging of follicle stimulating hormone receptors in gonads and bones using near infrared II fluorophoreCytokine detection and simultaneous assessment of rheumatoid factor interference in human serum and synovial fluid using high-sensitivity protein arrays on plasmonic gold chips.Reliable diagnosis of murine type 1 diabetes using a panel of autoantigens and "antigen surrogates" mounted onto a liquid array.Molecular imaging of biological systems with a clickable dye in the broad 800- to 1,700-nm near-infrared windowDelta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer's diseaseMultiplexed Anti-Toxoplasma IgG, IgM, and IgA Assay on Plasmonic Gold Chips: towards Making Mass Screening Possible with Dye Test Precision.Chemical Tools To Monitor and Manipulate Adaptive Immune Responses.Discovery of native autoantigens via antigen surrogate technology: application to type 1 diabetesProtein arrays for biomarker discovery in lupus.Advancing translational research with next-generation protein microarrays.Visible to Near-Infrared Fluorescence Enhanced Cellular Imaging on Plasmonic Gold Chips.Competitive volumetric bar-chart chip with real-time internal control for point-of-care diagnosticsRecent advances in molecular biomarkers for diabetes mellitus: a systematic review.Autoantibody profiling on a plasmonic nano-gold chip for the early detection of hypertensive heart disease.A microfluidic platform with digital readout and ultra-low detection limit for quantitative point-of-care diagnostics.The development of next-generation screening and diagnostic platforms will change diabetes care.Nanoporous Glass Integrated in Volumetric Bar-Chart Chip for Point-of-Care Diagnostics of Non-Small Cell Lung Cancer.Characterization of Growth Hormone Resistance in Experimental and Ulcerative Colitis.A Singlet Oxygen Generating Agent by Chirality-dependent Plasmonic Shell-Satellite Nanoassembly.Caspase-2 cleavage of tau reversibly impairs memory.Optimizing Multiplexed Detections of Diabetes Antibodies via Quantitative Microfluidic Droplet Array.Protein Arrays II: Antigen Arrays.Type 1 Diabetes Prevention: A Goal Dependent on Accepting a Diagnosis of an Asymptomatic Disease.Tau-based therapies in neurodegeneration: opportunities and challenges.Proteoliposome-based full-length ZnT8 self-antigen for type 1 diabetes diagnosis on a plasmonic platform.Asparagine endopeptidase cleaves α-synuclein and mediates pathologic activities in Parkinson's disease.Optical Properties and Plasmonic Performance of Titanium Nitride.Metabolic Fingerprinting on a Plasmonic Gold Chip for Mass Spectrometry Based in Vitro Diagnostics.
P2860
Q26782441-71BB5408-B1DF-41E8-9F6F-47E6954CC8AFQ28067188-C297E633-C0FE-4450-BB00-0313E6EC11D7Q28082768-ED6193D1-8DD5-4DFC-A605-CE78F75C91B1Q28391166-4E44EA04-4F6D-4010-9C9D-F685AEC221CFQ30391340-3E9938C1-0527-4E48-A07A-AC15E5D653C3Q33446855-B957AAE8-6AEC-4C33-A4CA-78F30B954892Q33781591-65A6FA1D-4D0A-4A23-B999-8053E1ECD0C5Q35744354-55557ED1-7059-4B79-960D-05056C159400Q35782179-D348A216-7EFD-4E81-9AC3-60180567997EQ36252011-6EE66A03-1FE6-45F5-B86A-2406B5BD38D4Q36320154-E2C817A5-B0C0-497F-A830-6D41E4C2C11CQ37040542-DBDC4564-5488-4A12-9A8D-35D5F21FA9E7Q37675090-54468DDB-CCD8-4F78-BC7D-01357E9776DCQ38446485-6F026DB9-3271-41CE-B635-5A189961D82FQ38673773-BF66FCB7-B807-445B-9815-57E25E80B485Q38691479-5BA2E34D-F52A-44B5-8304-C640C6FBB4C3Q38811907-13A6B33D-9A89-42D8-B366-AF387042BD3EQ38902218-D684D863-57D5-45E1-87BA-4B270F0BCF91Q39079275-93F37295-10A3-4DCD-AACE-23B7AB0B6920Q40153619-F57650C5-64B4-417D-B341-8E54126021C7Q40296107-88C08FF5-4923-4033-94EC-D60334A49479Q42278799-48657588-960E-4346-8E7F-83985FEC472AQ42430510-B0191DE2-92A5-40F1-800D-3358CE4C0E9FQ45872470-06B13CF9-6FD8-47D7-A4D3-FB587CD391AEQ46413572-6B97EE1E-4219-414D-97E9-76EB3BFADC07Q46467885-74EF1AAA-C1DE-42C0-8A3C-74B408EC0FB3Q47153962-8D8D1074-32EC-408C-96D4-56EF4027424DQ47593263-34DDDF46-BD73-44AE-9F1D-DEA49CE74817Q47594106-90734126-6B6D-4788-B601-A558016162EFQ47689697-5CDF698D-F184-4732-AF6B-64659335915EQ47713548-462384F1-0BFA-4409-9E5A-7A76C04447A8Q48186447-F30B1931-3513-41FA-A40A-41B5ED532962Q50196192-D386DBF3-E908-404A-A0C3-E06306702980Q51417509-3CEDCBAD-0655-4FDC-B49F-28CFD88BC8C0
P2860
A plasmonic chip for biomarker discovery and diagnosis of type 1 diabetes.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
A plasmonic chip for biomarker discovery and diagnosis of type 1 diabetes.
@ast
A plasmonic chip for biomarker discovery and diagnosis of type 1 diabetes.
@en
type
label
A plasmonic chip for biomarker discovery and diagnosis of type 1 diabetes.
@ast
A plasmonic chip for biomarker discovery and diagnosis of type 1 diabetes.
@en
prefLabel
A plasmonic chip for biomarker discovery and diagnosis of type 1 diabetes.
@ast
A plasmonic chip for biomarker discovery and diagnosis of type 1 diabetes.
@en
P2860
P356
P1433
P1476
A plasmonic chip for biomarker discovery and diagnosis of type 1 diabetes.
@en
P2093
Hongjie Dai
Rajiv B Kumar
P2860
P2888
P304
P356
10.1038/NM.3619
P407
P577
2014-07-13T00:00:00Z
P6179
1033667918